BlackRock Health Sciences Trust (NYSE: BME) Stock Competitors & Peer Comparison

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VSMPX has a market cap of 2.3T. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VSMPX trades at $345.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VSMPX's P/E ratio is 26.81. In terms of profitability, BME's ROE is +0.14%, compared to VSMPX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VSMPX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VSMPX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VTSAX has a market cap of 2.3T. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VTSAX trades at $184.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VTSAX's P/E ratio is 26.81. In terms of profitability, BME's ROE is +0.14%, compared to VTSAX's ROE of +0.08%. Regarding short-term risk, BME is more volatile compared to VTSAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VTSAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VITSX has a market cap of 2.3T. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VITSX trades at $184.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VITSX's P/E ratio is -1527.25. In terms of profitability, BME's ROE is +0.14%, compared to VITSX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VITSX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VITSX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, PMFLX has a market cap of 1.9T. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while PMFLX trades at $9.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas PMFLX's P/E ratio is N/A. In terms of profitability, BME's ROE is +0.14%, compared to PMFLX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to PMFLX. This indicates higher risk in terms of short-term price fluctuations for BME.Check PMFLX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VOO has a market cap of 1.7T. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VOO trades at $703.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VOO's P/E ratio is 27.47. In terms of profitability, BME's ROE is +0.14%, compared to VOO's ROE of +0.00%. Regarding short-term risk, BME is more volatile compared to VOO. This indicates higher risk in terms of short-term price fluctuations for BME.Check VOO's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VFFSX has a market cap of 1.7T. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VFFSX trades at $376.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VFFSX's P/E ratio is 27.34. In terms of profitability, BME's ROE is +0.14%, compared to VFFSX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VFFSX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VFFSX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VFIAX has a market cap of 1.7T. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VFIAX trades at $709.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VFIAX's P/E ratio is 27.34. In terms of profitability, BME's ROE is +0.14%, compared to VFIAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VFIAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VFIAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VFINX has a market cap of 1.7T. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VFINX trades at $709.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VFINX's P/E ratio is 27.35. In terms of profitability, BME's ROE is +0.14%, compared to VFINX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VFINX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VFINX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, FXAIX has a market cap of 832.5B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while FXAIX trades at $267.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas FXAIX's P/E ratio is N/A. In terms of profitability, BME's ROE is +0.14%, compared to FXAIX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to FXAIX. This indicates higher risk in terms of short-term price fluctuations for BME.Check FXAIX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, SPY has a market cap of 815.6B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while SPY trades at $765.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas SPY's P/E ratio is 25.94. In terms of profitability, BME's ROE is +0.14%, compared to SPY's ROE of +0.00%. Regarding short-term risk, BME is more volatile compared to SPY. This indicates higher risk in terms of short-term price fluctuations for BME.Check SPY's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VTIAX has a market cap of 666.5B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VTIAX trades at $47.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VTIAX's P/E ratio is 18.20. In terms of profitability, BME's ROE is +0.14%, compared to VTIAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VTIAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VTIAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VTPSX has a market cap of 666.4B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VTPSX trades at $188.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VTPSX's P/E ratio is 18.19. In terms of profitability, BME's ROE is +0.14%, compared to VTPSX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VTPSX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VTPSX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VTSNX has a market cap of 662.1B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VTSNX trades at $188.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VTSNX's P/E ratio is 18.19. In terms of profitability, BME's ROE is +0.14%, compared to VTSNX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VTSNX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VTSNX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, QQQ has a market cap of 508.4B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while QQQ trades at $713.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas QQQ's P/E ratio is 32.76. In terms of profitability, BME's ROE is +0.14%, compared to QQQ's ROE of +0.00%. Regarding short-term risk, BME is more volatile compared to QQQ. This indicates higher risk in terms of short-term price fluctuations for BME.Check QQQ's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, BMOP has a market cap of 434B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while BMOP trades at $24.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas BMOP's P/E ratio is N/A. In terms of profitability, BME's ROE is +0.14%, compared to BMOP's ROE of +0.00%. Regarding short-term risk, BME is more volatile compared to BMOP. This indicates higher risk in terms of short-term price fluctuations for BME.Check BMOP's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VBMFX has a market cap of 399.1B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VBMFX trades at $9.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VBMFX's P/E ratio is N/A. In terms of profitability, BME's ROE is +0.14%, compared to VBMFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VBMFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VBMFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VUG has a market cap of 389.4B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VUG trades at $87.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VUG's P/E ratio is 33.77. In terms of profitability, BME's ROE is +0.14%, compared to VUG's ROE of +0.00%. Regarding short-term risk, BME is more volatile compared to VUG. This indicates higher risk in terms of short-term price fluctuations for BME.Check VUG's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VIGAX has a market cap of 387.8B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VIGAX trades at $270.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VIGAX's P/E ratio is 33.63. In terms of profitability, BME's ROE is +0.14%, compared to VIGAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VIGAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VIGAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VIGIX has a market cap of 387.8B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VIGIX trades at $270.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VIGIX's P/E ratio is 33.63. In terms of profitability, BME's ROE is +0.14%, compared to VIGIX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VIGIX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VIGIX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, CGFAX has a market cap of 369.1B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while CGFAX trades at $86.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas CGFAX's P/E ratio is 33.36. In terms of profitability, BME's ROE is +0.14%, compared to CGFAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to CGFAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check CGFAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, GFFFX has a market cap of 366.5B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while GFFFX trades at $87.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas GFFFX's P/E ratio is 32.35. In terms of profitability, BME's ROE is +0.14%, compared to GFFFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to GFFFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check GFFFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, GFAFX has a market cap of 366.5B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while GFAFX trades at $87.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas GFAFX's P/E ratio is 33.12. In terms of profitability, BME's ROE is +0.14%, compared to GFAFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to GFAFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check GFAFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VIIIX has a market cap of 357.1B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VIIIX trades at $615.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VIIIX's P/E ratio is 27.34. In terms of profitability, BME's ROE is +0.14%, compared to VIIIX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VIIIX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VIIIX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VINIX has a market cap of 357.1B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VINIX trades at $615.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VINIX's P/E ratio is 27.34. In terms of profitability, BME's ROE is +0.14%, compared to VINIX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VINIX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VINIX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, GAFFX has a market cap of 353.6B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while GAFFX trades at $88.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas GAFFX's P/E ratio is 33.17. In terms of profitability, BME's ROE is +0.14%, compared to GAFFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to GAFFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check GAFFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, RGAGX has a market cap of 353.6B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while RGAGX trades at $88.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas RGAGX's P/E ratio is 33.17. In terms of profitability, BME's ROE is +0.14%, compared to RGAGX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to RGAGX. This indicates higher risk in terms of short-term price fluctuations for BME.Check RGAGX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, AGTHX has a market cap of 353.5B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while AGTHX trades at $88.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas AGTHX's P/E ratio is 33.13. In terms of profitability, BME's ROE is +0.14%, compared to AGTHX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to AGTHX. This indicates higher risk in terms of short-term price fluctuations for BME.Check AGTHX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VEA has a market cap of 328.1B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VEA trades at $73.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VEA's P/E ratio is 18.93. In terms of profitability, BME's ROE is +0.14%, compared to VEA's ROE of +0.00%. Regarding short-term risk, BME is more volatile compared to VEA. This indicates higher risk in terms of short-term price fluctuations for BME.Check VEA's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VTMGX has a market cap of 324.5B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VTMGX trades at $23.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VTMGX's P/E ratio is 18.73. In terms of profitability, BME's ROE is +0.14%, compared to VTMGX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VTMGX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VTMGX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VDIPX has a market cap of 324.5B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VDIPX trades at $36.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VDIPX's P/E ratio is 18.73. In terms of profitability, BME's ROE is +0.14%, compared to VDIPX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VDIPX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VDIPX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VTMNX has a market cap of 322.9B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VTMNX trades at $23.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VTMNX's P/E ratio is 18.73. In terms of profitability, BME's ROE is +0.14%, compared to VTMNX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VTMNX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VTMNX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, BALFX has a market cap of 291.5B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while BALFX trades at $41.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas BALFX's P/E ratio is 26.59. In terms of profitability, BME's ROE is +0.14%, compared to BALFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to BALFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check BALFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, AFMBX has a market cap of 291.5B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while AFMBX trades at $41.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas AFMBX's P/E ratio is 26.60. In terms of profitability, BME's ROE is +0.14%, compared to AFMBX's ROE of +0.13%. Regarding short-term risk, BME is more volatile compared to AFMBX. This indicates higher risk in terms of short-term price fluctuations for BME.Check AFMBX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, ABALX has a market cap of 291.5B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while ABALX trades at $41.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas ABALX's P/E ratio is 26.59. In terms of profitability, BME's ROE is +0.14%, compared to ABALX's ROE of +0.13%. Regarding short-term risk, BME is more volatile compared to ABALX. This indicates higher risk in terms of short-term price fluctuations for BME.Check ABALX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, CLBAX has a market cap of 287.1B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while CLBAX trades at $40.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas CLBAX's P/E ratio is 26.66. In terms of profitability, BME's ROE is +0.14%, compared to CLBAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to CLBAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check CLBAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, AMBFX has a market cap of 286.5B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while AMBFX trades at $41.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas AMBFX's P/E ratio is 26.60. In terms of profitability, BME's ROE is +0.14%, compared to AMBFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to AMBFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check AMBFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, RLBGX has a market cap of 286.4B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while RLBGX trades at $41.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas RLBGX's P/E ratio is 26.60. In terms of profitability, BME's ROE is +0.14%, compared to RLBGX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to RLBGX. This indicates higher risk in terms of short-term price fluctuations for BME.Check RLBGX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, RGABX has a market cap of 269.1B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while RGABX trades at $76.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas RGABX's P/E ratio is 32.14. In terms of profitability, BME's ROE is +0.14%, compared to RGABX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to RGABX. This indicates higher risk in terms of short-term price fluctuations for BME.Check RGABX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, RGAAX has a market cap of 264.1B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while RGAAX trades at $75.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas RGAAX's P/E ratio is 32.15. In terms of profitability, BME's ROE is +0.14%, compared to RGAAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to RGAAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check RGAAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, FCTDX has a market cap of 262.9B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while FCTDX trades at $22.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas FCTDX's P/E ratio is N/A. In terms of profitability, BME's ROE is +0.14%, compared to FCTDX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to FCTDX. This indicates higher risk in terms of short-term price fluctuations for BME.Check FCTDX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VTV has a market cap of 261.7B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VTV trades at $226.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VTV's P/E ratio is 22.39. In terms of profitability, BME's ROE is +0.14%, compared to VTV's ROE of +0.00%. Regarding short-term risk, BME is more volatile compared to VTV. This indicates higher risk in terms of short-term price fluctuations for BME.Check VTV's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VVIAX has a market cap of 260.5B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VVIAX trades at $88.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VVIAX's P/E ratio is 22.26. In terms of profitability, BME's ROE is +0.14%, compared to VVIAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VVIAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VVIAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, GFACX has a market cap of 257.2B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while GFACX trades at $73.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas GFACX's P/E ratio is 33.03. In terms of profitability, BME's ROE is +0.14%, compared to GFACX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to GFACX. This indicates higher risk in terms of short-term price fluctuations for BME.Check GFACX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, SWVXX has a market cap of 245.3B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while SWVXX trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas SWVXX's P/E ratio is N/A. In terms of profitability, BME's ROE is +0.14%, compared to SWVXX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to SWVXX. This indicates higher risk in terms of short-term price fluctuations for BME.Check SWVXX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, PONPX has a market cap of 231.8B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while PONPX trades at $10.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas PONPX's P/E ratio is N/A. In terms of profitability, BME's ROE is +0.14%, compared to PONPX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to PONPX. This indicates higher risk in terms of short-term price fluctuations for BME.Check PONPX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, PIMIX has a market cap of 231.8B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while PIMIX trades at $10.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas PIMIX's P/E ratio is N/A. In terms of profitability, BME's ROE is +0.14%, compared to PIMIX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to PIMIX. This indicates higher risk in terms of short-term price fluctuations for BME.Check PIMIX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VO has a market cap of 229.7B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VO trades at $82.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VO's P/E ratio is 24.57. In terms of profitability, BME's ROE is +0.14%, compared to VO's ROE of +0.00%. Regarding short-term risk, BME is more volatile compared to VO. This indicates higher risk in terms of short-term price fluctuations for BME.Check VO's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VMCPX has a market cap of 228.3B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VMCPX trades at $447.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VMCPX's P/E ratio is 24.43. In terms of profitability, BME's ROE is +0.14%, compared to VMCPX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VMCPX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VMCPX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VIMAX has a market cap of 228.3B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VIMAX trades at $411.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VIMAX's P/E ratio is 24.43. In terms of profitability, BME's ROE is +0.14%, compared to VIMAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VIMAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VIMAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VMCIX has a market cap of 228.3B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VMCIX trades at $90.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VMCIX's P/E ratio is 24.43. In terms of profitability, BME's ROE is +0.14%, compared to VMCIX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VMCIX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VMCIX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, ODIDX has a market cap of 213.2B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while ODIDX trades at $8.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas ODIDX's P/E ratio is N/A. In terms of profitability, BME's ROE is +0.14%, compared to ODIDX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to ODIDX. This indicates higher risk in terms of short-term price fluctuations for BME.Check ODIDX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VB has a market cap of 194.8B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VB trades at $304.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VB's P/E ratio is 22.29. In terms of profitability, BME's ROE is +0.14%, compared to VB's ROE of +0.00%. Regarding short-term risk, BME is more volatile compared to VB. This indicates higher risk in terms of short-term price fluctuations for BME.Check VB's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VSCIX has a market cap of 193.4B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VSCIX trades at $146.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VSCIX's P/E ratio is 22.13. In terms of profitability, BME's ROE is +0.14%, compared to VSCIX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VSCIX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VSCIX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VSMAX has a market cap of 193.4B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VSMAX trades at $146.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VSMAX's P/E ratio is 22.13. In terms of profitability, BME's ROE is +0.14%, compared to VSMAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VSMAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VSMAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, APO-PA has a market cap of 190.8B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while APO-PA trades at $170.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas APO-PA's P/E ratio is 20.43. In terms of profitability, BME's ROE is +0.14%, compared to APO-PA's ROE of +0.09%. Regarding short-term risk, BME is more volatile compared to APO-PA. This indicates higher risk in terms of short-term price fluctuations for BME.Check APO-PA's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, RICBX has a market cap of 185.9B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while RICBX trades at $68.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas RICBX's P/E ratio is 28.64. In terms of profitability, BME's ROE is +0.14%, compared to RICBX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to RICBX. This indicates higher risk in terms of short-term price fluctuations for BME.Check RICBX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, AICCX has a market cap of 185.9B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while AICCX trades at $67.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas AICCX's P/E ratio is 28.64. In terms of profitability, BME's ROE is +0.14%, compared to AICCX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to AICCX. This indicates higher risk in terms of short-term price fluctuations for BME.Check AICCX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, FCNKX has a market cap of 185B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while FCNKX trades at $26.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas FCNKX's P/E ratio is N/A. In terms of profitability, BME's ROE is +0.14%, compared to FCNKX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to FCNKX. This indicates higher risk in terms of short-term price fluctuations for BME.Check FCNKX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, FCNTX has a market cap of 185B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while FCNTX trades at $26.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas FCNTX's P/E ratio is N/A. In terms of profitability, BME's ROE is +0.14%, compared to FCNTX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to FCNTX. This indicates higher risk in terms of short-term price fluctuations for BME.Check FCNTX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, FUNFX has a market cap of 182.7B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while FUNFX trades at $103.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas FUNFX's P/E ratio is 28.88. In terms of profitability, BME's ROE is +0.14%, compared to FUNFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to FUNFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check FUNFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, FINFX has a market cap of 182.7B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while FINFX trades at $103.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas FINFX's P/E ratio is 28.87. In terms of profitability, BME's ROE is +0.14%, compared to FINFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to FINFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check FINFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, ANCFX has a market cap of 182.7B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while ANCFX trades at $103.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas ANCFX's P/E ratio is 28.87. In terms of profitability, BME's ROE is +0.14%, compared to ANCFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to ANCFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check ANCFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, CICAX has a market cap of 181.6B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while CICAX trades at $68.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas CICAX's P/E ratio is 28.88. In terms of profitability, BME's ROE is +0.14%, compared to CICAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to CICAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check CICAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, FFICX has a market cap of 180.3B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while FFICX trades at $69.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas FFICX's P/E ratio is 28.69. In terms of profitability, BME's ROE is +0.14%, compared to FFICX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to FFICX. This indicates higher risk in terms of short-term price fluctuations for BME.Check FFICX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, AICFX has a market cap of 180.3B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while AICFX trades at $68.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas AICFX's P/E ratio is 28.67. In terms of profitability, BME's ROE is +0.14%, compared to AICFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to AICFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check AICFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, AIVSX has a market cap of 180.3B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while AIVSX trades at $69.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas AIVSX's P/E ratio is 28.68. In terms of profitability, BME's ROE is +0.14%, compared to AIVSX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to AIVSX. This indicates higher risk in terms of short-term price fluctuations for BME.Check AIVSX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, RICAX has a market cap of 180.2B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while RICAX trades at $68.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas RICAX's P/E ratio is 28.64. In terms of profitability, BME's ROE is +0.14%, compared to RICAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to RICAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check RICAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, BLK has a market cap of 179.2B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while BLK trades at $1,156.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas BLK's P/E ratio is 22.60. In terms of profitability, BME's ROE is +0.14%, compared to BLK's ROE of +0.12%. Regarding short-term risk, BME is more volatile compared to BLK. This indicates higher risk in terms of short-term price fluctuations for BME.Check BLK's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, CFNAX has a market cap of 178.3B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while CFNAX trades at $103.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas CFNAX's P/E ratio is 28.91. In terms of profitability, BME's ROE is +0.14%, compared to CFNAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to CFNAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check CFNAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, AFIFX has a market cap of 178B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while AFIFX trades at $103.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas AFIFX's P/E ratio is 28.86. In terms of profitability, BME's ROE is +0.14%, compared to AFIFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to AFIFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check AFIFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, RFNCX has a market cap of 178B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while RFNCX trades at $103.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas RFNCX's P/E ratio is 28.85. In terms of profitability, BME's ROE is +0.14%, compared to RFNCX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to RFNCX. This indicates higher risk in terms of short-term price fluctuations for BME.Check RFNCX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, FNPFX has a market cap of 173.8B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while FNPFX trades at $76.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas FNPFX's P/E ratio is 27.33. In terms of profitability, BME's ROE is +0.14%, compared to FNPFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to FNPFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check FNPFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, NPFFX has a market cap of 173.7B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while NPFFX trades at $75.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas NPFFX's P/E ratio is 27.30. In terms of profitability, BME's ROE is +0.14%, compared to NPFFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to NPFFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check NPFFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, BX has a market cap of 170.8B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while BX trades at $143.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas BX's P/E ratio is 24.21. In terms of profitability, BME's ROE is +0.14%, compared to BX's ROE of +0.41%. Regarding short-term risk, BME is less volatile compared to BX. This indicates lower risk in terms of short-term price fluctuations for BME.Check BX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, RNPGX has a market cap of 169.9B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while RNPGX trades at $76.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas RNPGX's P/E ratio is 27.33. In terms of profitability, BME's ROE is +0.14%, compared to RNPGX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to RNPGX. This indicates higher risk in terms of short-term price fluctuations for BME.Check RNPGX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, ANWPX has a market cap of 169.9B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while ANWPX trades at $76.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas ANWPX's P/E ratio is 27.31. In terms of profitability, BME's ROE is +0.14%, compared to ANWPX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to ANWPX. This indicates higher risk in terms of short-term price fluctuations for BME.Check ANWPX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, RNPCX has a market cap of 169.9B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while RNPCX trades at $73.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas RNPCX's P/E ratio is 27.27. In terms of profitability, BME's ROE is +0.14%, compared to RNPCX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to RNPCX. This indicates higher risk in terms of short-term price fluctuations for BME.Check RNPCX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, SPCK has a market cap of 168B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while SPCK trades at $22.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas SPCK's P/E ratio is -20.16. In terms of profitability, BME's ROE is +0.14%, compared to SPCK's ROE of +0.00%. Regarding short-term risk, BME is more volatile compared to SPCK. This indicates higher risk in terms of short-term price fluctuations for BME.Check SPCK's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VEMRX has a market cap of 166.9B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VEMRX trades at $126.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VEMRX's P/E ratio is 16.88. In terms of profitability, BME's ROE is +0.14%, compared to VEMRX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VEMRX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VEMRX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VEMAX has a market cap of 165.2B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VEMAX trades at $50.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VEMAX's P/E ratio is 16.88. In terms of profitability, BME's ROE is +0.14%, compared to VEMAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VEMAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VEMAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, WGIFX has a market cap of 157.2B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while WGIFX trades at $82.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas WGIFX's P/E ratio is 25.44. In terms of profitability, BME's ROE is +0.14%, compared to WGIFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to WGIFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check WGIFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, FPMAX has a market cap of 154.3B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while FPMAX trades at $10.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas FPMAX's P/E ratio is N/A. In terms of profitability, BME's ROE is +0.14%, compared to FPMAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to FPMAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check FPMAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, AWSHX has a market cap of 154.2B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while AWSHX trades at $69.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas AWSHX's P/E ratio is 26.58. In terms of profitability, BME's ROE is +0.14%, compared to AWSHX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to AWSHX. This indicates higher risk in terms of short-term price fluctuations for BME.Check AWSHX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, RWMFX has a market cap of 154.1B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while RWMFX trades at $68.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas RWMFX's P/E ratio is 26.59. In terms of profitability, BME's ROE is +0.14%, compared to RWMFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to RWMFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check RWMFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, FWMIX has a market cap of 154.1B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while FWMIX trades at $68.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas FWMIX's P/E ratio is 26.59. In terms of profitability, BME's ROE is +0.14%, compared to FWMIX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to FWMIX. This indicates higher risk in terms of short-term price fluctuations for BME.Check FWMIX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, CWMAX has a market cap of 153.6B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while CWMAX trades at $68.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas CWMAX's P/E ratio is 26.58. In terms of profitability, BME's ROE is +0.14%, compared to CWMAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to CWMAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check CWMAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, WSHFX has a market cap of 153.2B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while WSHFX trades at $68.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas WSHFX's P/E ratio is 26.57. In terms of profitability, BME's ROE is +0.14%, compared to WSHFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to WSHFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check WSHFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, WSHCX has a market cap of 150.6B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while WSHCX trades at $67.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas WSHCX's P/E ratio is 26.53. In terms of profitability, BME's ROE is +0.14%, compared to WSHCX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to WSHCX. This indicates higher risk in terms of short-term price fluctuations for BME.Check WSHCX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, RWMBX has a market cap of 150.1B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while RWMBX trades at $67.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas RWMBX's P/E ratio is 26.52. In terms of profitability, BME's ROE is +0.14%, compared to RWMBX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to RWMBX. This indicates higher risk in terms of short-term price fluctuations for BME.Check RWMBX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, GLD has a market cap of 149.4B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while GLD trades at $423.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas GLD's P/E ratio is 232664.84. In terms of profitability, BME's ROE is +0.14%, compared to GLD's ROE of +0.00%. Regarding short-term risk, BME is more volatile compared to GLD. This indicates higher risk in terms of short-term price fluctuations for BME.Check GLD's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, SWPPX has a market cap of 147.1B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while SWPPX trades at $19.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas SWPPX's P/E ratio is 27.38. In terms of profitability, BME's ROE is +0.14%, compared to SWPPX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to SWPPX. This indicates higher risk in terms of short-term price fluctuations for BME.Check SWPPX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, FIFAX has a market cap of 146.7B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while FIFAX trades at $28.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas FIFAX's P/E ratio is 20.00. In terms of profitability, BME's ROE is +0.14%, compared to FIFAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to FIFAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check FIFAX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, RERGX has a market cap of 144.5B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while RERGX trades at $65.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas RERGX's P/E ratio is 19.72. In terms of profitability, BME's ROE is +0.14%, compared to RERGX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to RERGX. This indicates higher risk in terms of short-term price fluctuations for BME.Check RERGX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, AEGFX has a market cap of 144.5B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while AEGFX trades at $64.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas AEGFX's P/E ratio is 19.68. In terms of profitability, BME's ROE is +0.14%, compared to AEGFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to AEGFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check AEGFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, RERHX has a market cap of 142.6B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while RERHX trades at $64.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas RERHX's P/E ratio is 19.69. In terms of profitability, BME's ROE is +0.14%, compared to RERHX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to RERHX. This indicates higher risk in terms of short-term price fluctuations for BME.Check RERHX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, AEPFX has a market cap of 142.6B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while AEPFX trades at $65.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas AEPFX's P/E ratio is 19.71. In terms of profitability, BME's ROE is +0.14%, compared to AEPFX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to AEPFX. This indicates higher risk in terms of short-term price fluctuations for BME.Check AEPFX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, AEPGX has a market cap of 142.6B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while AEPGX trades at $65.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas AEPGX's P/E ratio is 19.69. In terms of profitability, BME's ROE is +0.14%, compared to AEPGX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to AEPGX. This indicates higher risk in terms of short-term price fluctuations for BME.Check AEPGX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, NAESX has a market cap of 139.7B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while NAESX trades at $146.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas NAESX's P/E ratio is 22.13. In terms of profitability, BME's ROE is +0.14%, compared to NAESX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to NAESX. This indicates higher risk in terms of short-term price fluctuations for BME.Check NAESX's competition here

BlackRock Health Sciences Trust (NYSE: BME) plays a significant role within the Financial Services sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BME stands at 596.6M. In comparison, VITAX has a market cap of 139.6B. Regarding current trading prices, BME is priced at $46.13 on the NYSE, while VITAX trades at $485.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BME currently has a P/E ratio of 73.97, whereas VITAX's P/E ratio is 35.55. In terms of profitability, BME's ROE is +0.14%, compared to VITAX's ROE of N/A. Regarding short-term risk, BME is more volatile compared to VITAX. This indicates higher risk in terms of short-term price fluctuations for BME.Check VITAX's competition here